SEC Filing | Company/Stock | Trade Date | Transaction | Shares | Avg. Price | Total | % Holdings | Gain/Loss |
---|---|---|---|---|---|---|---|---|
20-Nov-24 5:05 PM View: | Veralto Corp (VLTO) | 18-Nov-24 | Payment of Exercise | 3,833 | $102.68 | $393,572.00 | (8%) 50.11K to 46.28K | |
27-Feb-24 8:12 PM View: | Veralto Corp (VLTO) | 24-Feb-24 | Grant | 7,497 | -- | -- | 18% 42.62K to 50.11K | |
17-Nov-23 5:28 PM View: | Veralto Corp (VLTO) | 15-Nov-23 | Grant | 27,060 | -- | -- | 174% 15.56K to 42.62K | |
03-Oct-23 10:00 PM View: | Veralto Corp (VLTO) | 30-Sep-23 | Grant | 15,556 | -- | -- | 100% 0 to 15.56K | |
03-Mar-23 10:00 PM View: | Chemours Co (CC) | 01-Mar-23 | Grant | 12,378 | -- | -- | 3% 370.81K to 383.19K | |
03-Mar-23 10:00 PM View: | Chemours Co (CC) | 01-Mar-23 | Payment of Exercise | 1,842 | $34.84 | $64,175.30 | (< 1%) 383.19K to 381.35K | |
14-Feb-23 2:22 PM View: | Chemours Co (CC) | 10-Feb-23 | Grant | 98,360 | -- | -- | 31% 314.57K to 412.93K | |
14-Feb-23 2:22 PM View: | Chemours Co (CC) | 10-Feb-23 | Payment of Exercise | 42,218 | $34.35 | $1,450,190.00 | (10%) 412.93K to 370.71K | |
09-May-22 6:21 PM View: | Chemours Co (CC) | 09-May-22 | Option Exercise | 20,175 | $5.40 | $108,945.00 | 6% 313.51K to 333.68K | |
09-May-22 6:21 PM View: | Chemours Co (CC) | 09-May-22 | Option Sale | 20,175 | $40.01 | $807,202.00 | (6%) 333.68K to 313.51K | |
09-May-22 6:21 PM View: | Chemours Co (CC) | 06-May-22 | Option Exercise | 35,188 | $5.40 | $190,015.00 | 11% 313.51K to 348.69K | |
09-May-22 6:21 PM View: | Chemours Co (CC) | 06-May-22 | Option Sale | 35,188 | $40.14 | $1,412,450.00 | (10%) 348.69K to 313.51K | |
03-Mar-22 8:53 AM View: | Chemours Co (CC) | 01-Mar-22 | Grant | 6,254 | -- | -- | 2% 307.39K to 313.64K | |
03-Mar-22 8:53 AM View: | Chemours Co (CC) | 01-Mar-22 | Payment of Exercise | 550 | $25.98 | $14,289.00 | (< 1%) 313.64K to 313.09K | |
15-Feb-22 6:52 PM View: | Chemours Co (CC) | 11-Feb-22 | Grant | 11,864 | -- | -- | 4% 299.5K to 311.36K | |
15-Feb-22 6:52 PM View: | Chemours Co (CC) | 11-Feb-22 | Payment of Exercise | 3,975 | $30.00 | $119,250.00 | (1%) 311.36K to 307.39K | |
03-Dec-21 5:28 PM View: | Chemours Co (CC) | 02-Dec-21 | Option Exercise | 17,482 | $18.45 | $322,543.00 | 6% 299.15K to 316.63K | |
03-Dec-21 5:28 PM View: | Chemours Co (CC) | 02-Dec-21 | Market Option Sale (Planned) | 17,482 | $29.85 | $521,838.00 | (6%) 316.63K to 299.15K | |
30-Aug-21 7:56 PM View: | Chemours Co (CC) | 30-Aug-21 | Option Exercise | 1,890 | $18.45 | $34,870.50 | < 1% 298.79K to 300.68K | |
30-Aug-21 7:56 PM View: | Chemours Co (CC) | 30-Aug-21 | Market Option Sale (Planned) | 1,890 | $35.00 | $66,150.00 | (< 1%) 300.68K to 298.79K | |
30-Aug-21 10:00 PM View: | Chemours Co (CC) | 27-Aug-21 | Option Exercise | 15,085 | $18.45 | $278,318.00 | 5% 298.79K to 313.88K | |
30-Aug-21 10:00 PM View: | Chemours Co (CC) | 27-Aug-21 | Market Option Sale (Planned) | 15,085 | $35.00 | $527,975.00 | (5%) 313.88K to 298.79K | |
03-Mar-21 1:16 PM View: | Chemours Co (CC) | 01-Mar-21 | Grant | 4,997 | -- | -- | 2% 293.12K to 298.12K | |
17-Feb-21 5:13 PM View: | Chemours Co (CC) | 12-Feb-21 | Grant | 597 | -- | -- | < 1% 292.75K to 293.34K | |
17-Feb-21 5:13 PM View: | Chemours Co (CC) | 12-Feb-21 | Payment of Exercise | 224 | $26.14 | $5,855.36 | (< 1%) 293.34K to 293.12K | |
03-Dec-20 12:46 PM View: | Chemours Co (CC) | 01-Dec-20 | Grant | 39,510 | -- | -- | 16% 253.14K to 292.65K | |
19-Feb-20 9:53 PM View: | Chemours Co (CC) | 14-Feb-20 | Grant | 5,467 | -- | -- | 2% 249.67K to 255.14K | |
19-Feb-20 9:53 PM View: | Chemours Co (CC) | 14-Feb-20 | Payment of Exercise | 2,002 | $19.37 | $38,778.70 | (< 1%) 255.14K to 253.14K | (29%) |